Abstract:Background: Beyond magnetic resonance imaging (MRI), which has been widely used clinically, molecular MRI (mMRI) can further provide qualitative and quantitative information at the cellular and molecular levels. However, the diagnostic accuracy may not be satisfactory via single-contrast mMRI due to some interferences in vivo. T-1/T-2 dual-contrast MRI using the same contrast agent (CA) could significantly improve the detection accuracy. Therefore, in this study, we fabricated poly(ethylene glycol) (PEG)-coated, manganese-doped iron oxide nanocomposites (Mn-IONPs@PEG) as T-1/T-2 dual-contrast CA, and evaluated its feasibility of T-1/T-2 dual-contrast MRI in vitro and in vivo. Methods: Mn-IONPs were prepared by the thermal decomposition of iron-eruciate and manganese-oleate complexes and were coated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy[polyethylene glycol]-2000) (DSPE-PEG 2000). The physicochemical properties and cytotoxicity of the Mn-IONPs were fully characterized, followed by MRI in vitro and in vivo. Results: Ultrasmall 3 nm-sized nanoparticles were successfully prepared and were identified using transmission electron microscopy (TEM), high-resolution TEM, and X-ray diffraction. After coating with DSPE-PEG, the Mn-IONPs@PEG displayed excellent hydrophilicity and good biocompatibility. Due to the manganese-doping and PEG coating, the Mn-IONPs@PEG showed good relaxivity in vitro. Especially, the Mn-IONPs@PEG coated with DSPE-PEG following a mass ratio to Mn-IONPs of 1:20 showed harmonious longitudinal relaxivity (r(1) = 7.1 mM(-1) s(-1)) and transversal relaxivity (r(2) = 120.9 mM(-1) s(-1)), making it a better candidate for T-1/T-2 dual-contrast mMRI. After administrated via a caudal vein, the Mn-IONPs@PEG can induce significant enhancement in both T-1-weighted and T-2-weighted MR images and the time at 10 mins after injection was regarded as a suitable time for imaging because both the T-1 and T-2 enhancement were optimum at that time. Conclusion: The obtained Mn-IONPs@PEG exhibited good r(1) and r(2) and was a reasonable candidate for T-1/T-2 dual-contrast mMRI.

Synergistic Enhancement of Iron Oxide Nanoparticle and Gadolinium for Dual-Contrast MRI.

A Synergistically Enhanced T-1-T-2 Dual-Modal Contrast Agent

A Synergistically Enhanced <i>T</i><sub>1</sub>–<i>T</i><sub>2</sub> Dual‐Modal Contrast Agent

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Simultaneous Enhancement of T1 and T2 Magnetic Resonance Imaging of Liver Tumor at Respective Low and High Magnetic Fields.

Highly Sensitive T-1-T-2 Dual-Mode Mri Probe Based On Ultra-Small Gadolinium Oxide-Decorated Iron Oxide Nanocrystals

Gadolinium-based contrast agents for tumor targeting imaging

Targeted Dual-Contrast T1- and T2-weighted Magnetic Resonance Imaging of Tumors Using Multifunctional Gadolinium-Labeled Superparamagnetic Iron Oxide Nanoparticles

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Improving Longitudinal Transversal Relaxation of Gadolinium Chelate Using Silica Coating Magnetite Nanoparticles

Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.

Ultrasmall Water‐Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles As Positive and Negative Dual Contrast Agents

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Core/Shell Fe3o4/Gd2o3 Nanocubes As T-1-T-2 Dual Modal Mri Contrast Agents

An Albumin-Binding T-1-T-2 Dual-Modal MRI Contrast Agents for Improved Sensitivity and Accuracy in Tumor Imaging

Gd and Eu Co-Doped Nanoscale Metal–Organic Framework As a T1–T2 Dual-Modal Contrast Agent for Magnetic Resonance Imaging

Integration of PEG-conjugated Gadolinium Complex and Superparamagnetic Iron Oxide Nanoparticles As T1-T2 Dual-Mode Magnetic Resonance Imaging Probes

A Tumor Microenvironment Dual Responsive Contrast Agent for Contrary Contrast-Magnetic Resonance Imaging and Specific Chemotherapy of Tumors

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

The Adjacent Effect Between Gd(III) and Cu(II) in Layered Double Hydroxide Nanoparticles Synergistically Enhances T1-weighted Magnetic Resonance Imaging Contrast.

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging